Exencial Wealth Advisors’s PAVmed PAVM Stock Holding History

Exencial Wealth Advisors’s Portfolio PAVM Stock Details PAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-363	Closed	-$6.84K	–	512
2024 Q4	$6.84K	Buy	+363	New	+$10.7K	﹤0.01%	499

Other funds holding PAVM

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

OWP

Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exencial Wealth Advisors's PAVM Position: Q1 2025 in Review

Exencial Wealth Advisors sold out of PAVmed (PAVM) in Q1 2025, closing a stake of 363 shares — an estimated $6.84K sold.

Exencial Wealth Advisors first reported a position in PAVM in Q4 2024 and held it in 1 quarter. The position peaked at $6.84K in Q4 2024. 29 funds tracked by Wall St. Rank hold PAVM as of Q1 2025.

Exencial Wealth Advisors reported no remaining PAVmed position as of Q1 2025 after selling out during the quarter.
Exencial Wealth Advisors sold 363 PAVmed shares in Q1 2025, an estimated $6.84K.
Exencial Wealth Advisors first reported a position in PAVmed in Q4 2024 and held it in 1 quarter.
Exencial Wealth Advisors's PAVmed position peaked at $6.84K in Q4 2024.
29 funds tracked by Wall St. Rank held PAVmed as of Q1 2025.

Based on Exencial Wealth Advisors's 13F filing for Q1 2025, filed 9 May 2025.